Interstitial Lung Disease Remains Major a Diagnostic Challenge

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

pf_major challenge

Veracyte, Inc.recently presented four abstracts on current diagnostic challenges related to interstitial lung disease (ILD) and the potential for improved diagnostic procedures using novel genomic-based strategies. The abstracts were given at the Pulmonary Fibrosis Foundation’s PFF Summit 2015: From Bench to Bedside at the JW Marriott Hotel in Washington, D.C., in November.

Read more: